DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for Intramedullary Hip Screws 2017 - MedCore" report to their offering.
The U.S. market for IM hip devices defined in this report as IM nails used in the hip, also known as cephalomedullury nails, trochanteric nails or simply troch nails that are broken down by material type.
The U.S. market for intramedullary hip screws will be strongly influenced by increasing unit sales in the titanium hip screw market. Though there will be a strong decline in unit sales for the stainless steel intramedullary hip screw market, this segment is so small that the strong growth of the titanium market will be enough to drive the market. Strong growth projections are also being driven by ASP increases for these products to match inflation. Strong growth is expected to continue for the IM screw market as the obese and diabetic patient population expands dramatically. It has been well documented that high-energy traumatic injuries in obese patients often include orthopedic injuries to the pelvis or lower extremities, which often require devices such as intramedullary hip screws.
Due to the growing acceptance of its higher biocompatibility and lower weight in comparison with stainless steel or cobalt/chrome alloys, titanium is the material of choice in the intramedullary hip screw market. The increased costs associated with using titanium products will be a strong factor in the size of the market and its growth.
Companies Mentioned
- DePuy Synthes
- Stryker
- Zimmer Biomet
- Smith & Nephew
- Bioventus
- Wright Medical
- Acumed
- Orthofix
- Arthrex
- DJO Global
- I.T.S
- Integra LifeSciences
- BioPro
- ConMed
- OsteoMed
- Vilex
For more information about this report visit http://www.researchandmarkets.com/research/m8q722/us_market_report
